Global X Management Company’s Juno Therapeutics, Inc. JUNO Stock Holding History

Global X Management Company’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,282	Closed	-$104K	–	1151
2017 Q4	$104K	Buy	2,282 +574	+34%	+$28.6K	﹤0.01%	852
2017 Q3	$77K	Buy	1,708 +135	+9%	+$4.6K	﹤0.01%	888
2017 Q2	$47K	Buy	1,573 +793	+102%	+$19.6K	﹤0.01%	977
2017 Q1	$17K	Buy	780 +541	+226%	+$11.6K	﹤0.01%	1108
2016 Q4	$5K	Buy	239 +9	+4%	+$220	﹤0.01%	1065
2016 Q3	$7K	Hold	230	–	–	﹤0.01%	1046
2016 Q2	$9K	Buy	+230	New	+$9.55K	﹤0.01%	897

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Global X Management Company's JUNO Position: Q1 2018 in Review

Global X Management Company sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 2,282 shares — an estimated $104K sold.

Global X Management Company first reported a position in JUNO in Q2 2016 and held it in 7 quarters. The position peaked at $104K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Global X Management Company reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Global X Management Company sold 2,282 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $104K.
Global X Management Company first reported a position in Juno Therapeutics, Inc. in Q2 2016 and held it in 7 quarters.
Global X Management Company's Juno Therapeutics, Inc. position peaked at $104K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Global X Management Company's 13F filing for Q1 2018, filed 2 May 2018.